Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen
University / College
Location:
Aachen,
Germany (DE)
ISNI: 000000010728696X
ROR: https://ror.org/04xfq0f34
A model-specific simplification of the Mouse Grimace Scale based on the pain response of intraperitoneal CCl4 injections (2022)
Ernst L, Bruch S, Kopaczka M, Merhof D, Bleich A, Tolba RH, Talbot SR
Journal article
The Medical Segmentation Decathlon (2022)
Antonelli M, Reinke A, Bakas S, Farahani K, Kopp-Schneider A, Landman BA, Litjens G, et al.
Journal article
Cardiovascular Risk Profiles and Pre-Existing Health Conditions of Trekkers in the Solu-Khumbu Region, Nepal (2022)
Haunolder M, Apel C, Bertsch D, Cerfontaine C, Van Der Giet M, Van Der Giet S, Grass M, et al.
Journal article
Outcomes, Return to Sport, and Failures of MPFL Reconstruction Using Autografts in Children and Adolescents with Recurrent Patellofemoral Instability: A Systematic Review (2022)
Migliorini F, Maffulli N, Bell A, Betsch M
Journal article, Review article
Companion Rescue and Risk Management of Trekkers on the Everest Trek, Solo Khumbu Region, Nepal (2022)
Cerfontaine C, Apel C, Bertsch D, Grass M, Haunolder M, Hundt N, Jäger J, et al.
Journal article
Induction of severe hypoxemia and low lung recruitability for the evaluation of therapeutic ventilation strategies: a translational model of combined surfactant-depletion and ventilator-induced lung injury (2022)
Boerger E, Russ M, Von Platen P, Taher M, Hinken L, Pomprapa A, Koebrich R, et al.
Journal article
Blocking the CD47-Sirpa Axis Enhances Tafasitamab-Mediated Phagocytosis (2022)
Biedermann A, Mangelberger-Eberl D, Mougiakakos D, Büttner-Herold M, Flamann C, Kellner C, Altmeyer S, et al.
Conference contribution
Tandem Duplications of the UBTF gene in Adult AML: A Rare but Recurrent Alteration Associated with Myelodysplasia and Poor Outcome (2022)
Georgi JA, Stasik S, Zukunft S, Hartwig M, Roellig C, Oelschlaegel U, Krug U, et al.
Conference contribution
ASXL1 Mutations Predict Inferior Molecular Response to Nilotinib Treatment in Newly Diagnosed Patients with Chronic Myeloid Leukemia in Chronic Phase (2022)
Ernst T, Schoenfeld L, Rinke J, Hinze A, Nagel SN, Schaefer V, Schenk T, et al.
Conference contribution
LOMUSTINE/TEMOZOLOMIDE CHEMOTHERAPY FOR NEWLY DIAGNOSED MGMT-METHYLATED IDHWT GLIOBLASTOMA ACCORDING TO CETEG/NOA-09: REAL-WORLD EXPERIENCE IN A MULTICENTER COHORT (2022)
Weller J, Zeyen T, Schlegel U, Lazaridis L, Werner JM, Onken J, Zeiner P, et al.
Conference contribution